13F: Klingenstein Fields & Co LLC Has Cut Its Teva Pharmaceutical Industries (TEVA) Position by $4.04 Million as Stock Price Declined
Klingenstein Fields & Co Llc decreased its stake in Teva Pharmaceutical Industries (TEVA) by 45.58% based on its latest 2016Q3 regulatory filing with the SEC. Klingenstein Fields & Co Llc sold 87,893 shares as the company’s stock declined 8.07% while stock markets rallied. The institutional investor held 104,954 shares of the major pharmaceuticals company at the end of 2016Q3, valued at $4.83M, down from 192,847 at the end of the previous reported quarter. Klingenstein Fields & Co Llc who had been investing in Teva Pharmaceutical Industries.